HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Polyphosphate in Antiviral Protection: A Polyanionic Inorganic Polymer in the Fight Against Coronavirus SARS-CoV-2 Infection.

Abstract
Polyanions as polymers carrying multiple negative charges have been extensively studied with regard to their potential antiviral activity. Most studies to date focused on organic polyanionic polymers, both natural and synthetic. The inorganic polymer, polyphosphate (polyP), despite the ubiquitous presence of this molecule from bacteria to man, has attracted much less attention. More recently, and accelerated by the search for potential antiviral agents in the fight against the pandemic caused by the coronavirus SARS-CoV-2, it turned out that polyP disrupts the first step of the viral replication cycle, the interaction of the proteins in the virus envelope and in the cell membrane that are involved in the docking process of the virus with the target host cell. Experiments on a molecular level using the receptor-binding domain (RBD) of the SARS-CoV-2 spike protein and the cellular angiotensin converting enzyme 2 (ACE2) receptor revealed that polyP strongly inhibits the binding reaction through an electrostatic interaction between the negatively charged centers of the polyP molecule and a cationic groove, which is formed by positively charged amino acids on the RBD surface. In addition, it was found that polyP, due to its morphogenetic and energy delivering activities, enhances the antiviral host innate immunity defense of the respiratory epithelium. The underlying mechanisms and envisaged application of polyP in the therapy and prevention of COVID-19 are discussed.
AuthorsWerner E G Müller, Xiaohong Wang, Meik Neufurth, Heinz C Schröder
JournalProgress in molecular and subcellular biology (Prog Mol Subcell Biol) Vol. 61 Pg. 145-189 ( 2022) ISSN: 0079-6484 [Print] United States
PMID35697940 (Publication Type: Journal Article)
Copyright© 2022. The Author(s), under exclusive license to Springer Nature Switzerland AG.
Chemical References
  • Antiviral Agents
  • Polyelectrolytes
  • Polymers
  • Polyphosphates
  • Spike Glycoprotein, Coronavirus
  • polyanions
  • spike protein, SARS-CoV-2
Topics
  • Antiviral Agents (chemistry, therapeutic use)
  • Humans
  • Polyelectrolytes
  • Polymers
  • Polyphosphates (chemistry)
  • SARS-CoV-2
  • Spike Glycoprotein, Coronavirus
  • COVID-19 Drug Treatment

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: